𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Risk disclosure and preclinical Alzheimer’s disease clinical trial enrollment

✍ Scribed by Grill, Joshua D.; Karlawish, Jason; Elashoff, David; Vickrey, Barbara G.

Book ID
123267434
Publisher
Elsevier Science
Year
2013
Tongue
English
Weight
178 KB
Volume
9
Category
Article
ISSN
1552-5260

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Alzheimer's disease: clinical trials and
Alzheimer's disease: clinical trials and drug development
✍ Francesca Mangialasche; Alina Solomon; Bengt Winblad; Patrizia Mecocci; Miia Kiv 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 230 KB

Alzheimer's disease is the most common cause of dementia in elderly people. Research into Alzheimer's disease therapy has been at least partly successful in terms of developing symptomatic treatments, but has also had several failures in terms of developing disease-modifying therapies. These success